Altimmune, Inc. (ALT) CEO Vipin Garg on Q3 2020 Results - Earnings Call Transcript

Altimmune, Inc. (NASDAQ:ALT) Q3 2020 Earnings Conference Call November 10, 2020 8:30 AM ET

Company Participants

Stacey Jurchison - Investor Relations
Vipin Garg - Chief Executive Officer
Scot Roberts - Chief Scientific Officer
Scott Harris - Chief Medical Officer
Will Brown - Chief Financial Officer

Conference Call Participants

Yasmeen Rahimi - Piper Sandler
Mayank Mamtani - B. Riley FBR
Jon Wolleben - JMP Securities

Operator

Good morning and welcome to the Altimmune, Inc. Third Quarter 2020 Earnings Conference Call. All participants will be in listen-only mode. [Operator Instructions] After today’s presentation, there will be an opportunity to ask questions. Please note, this event is being recorded.

I would now like to turn the conference over to Stacey Jurchison. Please, go ahead.

Stacey Jurchison

Thank you, operator, and thank you everyone for participating in Altimmune's third quarter 2020 earnings conference call. Leading the call today will be Vipin Garg, Chief Executive Officer of Altimmune. Other members of the Altimmune executive team participating on the call today are Will Brown, Chief Financial Officer; Scot Roberts, Chief Scientific Officer; and Scott Harris, Chief Medical Officer.

After the prepared remarks, we will hold a question-and-answer session. A press release with our third quarter 2020 financial results was issued last night and can be found on the IR section of our website.

Before we begin, I'd like to remind everyone that remarks about future expectations, plans and prospects constitute forward-looking statements for purposes of Safe Harbor provisions under the Private Securities Litigation Reform Act of 1995. Altimmune cautions that these forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those indicated, including those related to COVID-19 and its impact on our business operations, clinical trials and results of operations.

For a discussion of some of the risks